Clinical Trial Update: A Study of Clofarabine in Older Patients With Acute Myeloid Leukemia (AML) for Whom Chemotherapy Is Not Suitable [Phase 2]

View source ↗

Summary

This document reports the results of a Phase 2 trial evaluating clofarabine in older patients with acute myeloid leukemia who are not suitable for conventional …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clolar (Clofarabine)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2015-04-01